Are you really measuring everything that matters when evaluating an ingredient or a formulation?

In the Health & Care market, many promising ingredients and formulations never reach their full potential, not because they lack efficacy, but because the biological mechanisms behind their effects are only partially measured.

When evaluation relies on a narrow set of endpoints, early molecular signals can be missed, mechanisms remain unclear, and strong claim directions remain underexplored.

To address this gap, Complife has developed a discovery-first molecular biology platform at its laboratories at CAAD, in Novara (Center for translational research on Autoimmune and Allergic Diseases at the University of Piedmont). The goal is simple: generate evidence that is earlier, deeper, and more actionable by capturing three layers of insight

• what is present, mapping key biological components of the system under investigation.
• what changes after treatment, by detecting molecular and microbial shifts induced by ingredients or formulations over time,
• how the biological system responds, by linking these changes to functional pathways, interactions, and potential mechanisms of action.

High-resolution microbiome intelligence

Using Oxford Nanopore sequencing, we profile complex bacterial and fungal ecosystems, mapping shifts in microbial communities across conditions, timepoints, and treatment groups.

These analyses can be performed:

• in vivo, using samples collected from volunteers
• in vitro, using advanced 3D tissue models

By applying the same sequencing-driven readouts across both settings, projects can generate microbiome evidence that is consistent from early screening through to applied validation.

Rapid identification of microbial isolates

We also provide fast and accurate identification of bacterial and fungal isolates using Nanopore sequencing, ideal for confirming cultured isolates, clarifying unknown organisms, or supporting targeted screening in product development and quality investigations.

By adopting a discovery-oriented approach from the earliest stages, Complife helps transform biological complexity into actionable insight, supporting informed development decisions and stronger scientific narratives.

Explore how our discovery-first molecular biology platform can support your next Health & Care project – contact the Complife team to discuss your study design

TELL US ABOUT YOUR PROJECTS.